The microvascular complications are the important cause of mortality and morbidity of either type 1 or 2 DM. Great efforts have been made to recognize the possible susceptibility or etiologic factors of these complications; whether genetic or environmental. Hepatitis C virus infection is another prevalent problem in our community. The present work aimed to study the possible impact, if any of HCV infection on microvascular complications. A total 70 diabetic patients 17 type 1 and 53 type 2, were included (20 males and 50 females) with age ranging from 13 to 72 years and 30 healthy volunteers with matched age and sex were taken as a control group. Complete history taking and full clinical examination were done. Laboratory work up was done for patients and control including urinalysis, blood sugar, serum creatinine, urinary albumin excretion, lipogram, liver function tests, HbAlc and HCV antibodies. Fundus examination was done for patients and control. Diabetics were found to have a prevalence rate of HCV infection of 32%. Prevalence of microvascular complication, nephropathy, retinopathy & neuropathy were found to be relatively higher in diabetics with HCV infection. Advanced grades of microvascular complication were more prevalent in HCV-positive diabetics. It was concluded that HCV infection is possibly a potential aggravating factor for microvascualr complications.
Introduction
he prevalence of diabetes and its complications is increasing nowadays. Vascular complications of DM are a common cause of mortality and morbidity in diabetics. These complications constitute the major clinical burden in diabetes but their pathogenesis is poorly understood 1 . Type 1 and 2 diabetes have the distinct etiologies, but patients with either disease are at risk of developing the same range of microvascular and macrovascular complications including nephropathy, neuropathy, retinopathy and atherosclerosis. Throughout the world, the number of patients requiring hemodialysis for diabetic nephropathy has increased enormously 2 . Although several factors, such as poor glucose control 3 , increased BP 4 , proteinuria 5 , lipid abnormalities 6 , and genetic problems 7 , can be identified contributing to the progression of diabetic nephropathy, it is highly suspected that there may be other prognostic factors for the deterioration of this disease. Hyperglycemia advanced glycosylation end products (AGES), growth factors and cytokines together with other factors have been identified as participants in the pathogenesis of these complications 3 . Type 2 diabetes is more common in those with than in those without HCV infection 8 . Thus HCV promote the development of type 2 diabetes in susceptible individuals. Hepatic steatosis and cirrhosis, both features of HCV infection, have been associated with abnormal glucose regulation 9 and insulin resistance 10 . Interestingly, a high prevalence of HCV infection was recently reported in diabetic patients 11 .
Mixed cryoglobulinemia, renal syndromes, lymphoproliferative disorders, Sjogren syndrome, porphyria cutanea tarda, and neuropathies are all strongly associated with hepatitis C virus (HCV) infection. Diabetes, thyroid disease, and the presence of autoantibodies in the serum are also linked to HCV, but less strongly. The pathophysiologic basis for most of these syndromes seems immunologic 12 .
The prevalence of HCV infection was investigated in the biopsied patients. The highest prevalence of HCV infection was found in type 2 diabetic-related glomerulosclerosis (II-DGS) 13 . The patient's positive for HCV antibody with diabetic glomerulosclerosis may rapidly progress to end-stage renal failure and need hemodialysis. The decline of renal function reflected by the slope of reciprocal serum creatinine was significantly greater in the HCV-positive group than in the HCV-negative group 14 . The present work aimed to study the impact of HCV infection, if any on the diabetic microvascular complications regarding nephropathy, retinopathy and neuropathy.
Material and Methods
Patients of the present work were recruited from that regularly attending outpatient clinic of diabetes and endocrine unit, Mansoura Specialized Medical University Hospital. A total of 70 diabetic patients ( 
Results
t-test was applied for numbers and chisquare for percentages (Tables 1-7) .
Discussion
Both hepatitis C virus infection and diabetes are common health problems in our country. Hepatitis C virus is known to have a wide variety of manifestations in the kidney. The renal manifestations of HCV include direct effects in the kidney, such as membranous nephropathy, cryoglobulinemia, and membranoproliferative type of the glomerulonephritis. The presence of HCV worsens the progression of several renal diseases, and, like chronic renal disease, HCV is more prevalent in patients with type 2 diabetic nephropathy. Therefore, it is possible that HCV contributes to the excess of renal disease 10, 14 . In the present study, prevalence rate of HCV infection among diabetics was found to be 25 out of 70 (35.7%) and it is significantly higher (10%) than normal control (Table 1) . Type 2 diabetes is more common in those with than in those without HCV infection. Thus HCV promote the development of type 2 diabetes in susceptible individuals 17, 8 . Hepatic steatosis and cirrhosis, both features of HCV infection, have been associated with glucose regulation and insulin resistance 18 . It was also found that diabetics having HCV infection are more at risk to develop macroalbuminuria (Table 4) and proliferative retinopathy (Table 6 ) than those without HCV infection are. Moreover, the overall prevalence of proteinuria and retinopathy was higher in HCV-positive compared to HCVnegative diabetics (Table 2 ). The degree of proteinuria was significantly greater in HCV-positive diabetic patients (111 79) than in HCVnegative diabetic patients (43 35). Serum creatinine levels and mean arterial pressure tended to be higher in HCV-positive diabetic patients (0.97 0.12 mg%, 104 6) than in HCVnegative diabetic patients (0.81 0.11mg%, 93 15) respectively (Table  2) . These results and the association of the degree of proteinuria with the deterioration of renal function emphasize that HCV infection may influence the progression of diabetic nephropathy.
Unlike our study, the Japanese study did not show a significant difference in progression to ESRD between HCV and non-HCV diabetic patients 11 . However, similar to our findings, the rate of progression of renal disease was worse in the HCV group 19 . We can only speculate as to why diabetic patients with HCV have worse renal survival. However, we have observed in a separate work that an elevated anti-nuclear antibody predicts worsens renal survival in a cohort of diabetic and nondiabetic HCV patients. Whether this serologic test indicates increased autoimmunity, which is J T U Med Sc 2007; 2 (1, 2) sometimes seen with HCV, or is a marker for increased inflammation or both is not clear at this time. Poorer renal survival in the HCV group may be due to direct effects of HCV in the kidney. It was due to HCV-related glomerular disease 19 . Ferri and his co-workers 20 We have some interesting theories. Immune complex glomerulonephritis has been reported to occur at a higher frequency in patients with diabetic nephropathy than in the nondiabetic population (23) . We must bear in mind that associated immune mediated glomerulonephritis in patients with diabetic nephropathy usually displays a rapid progression to renal failure 25 . (Table  3) . Other non-diabetic causes should be scrutinized but, in absence of renal biopsy it seems difficult to suggest HCV infection to be behind, at least, some of these cases. Obviously, further studies are needed to clarify this issue. Diabetic retinopathy is known to be present in virtually all diabetics with nephropathy, and absence of retinopathy should lead to more than usual consideration of other nondiabetic causes of renal disease 27 . Renal biopsies were done in patients with diabetes because the history was inconsistent with diabetic nephropathy (hematuria, heavy proteinuria in absence of retinopathy, or short history of diabetes). Likewise, it found that diabetic patients with HCV were less likely to have diabetic nephropathy as their primary diagnosis. On the other hand, 3 out of 9 cases with retinopathy and HCV infection did not have proteinuria (Table 5 ). West and his co-workers 29 confirmed that up to one third of cases with diabetic retinopathy, even of the proliferative type, may occur in absence of renal disease or proteinuria. Physicians who confirm the presence of HCV in patients with diabetes, should be aware of their increased risk for advanced diabetic nephropathy and should pay close attention to other modifiable risk factors, such as blood pressure control. It is important that prospective studies be performed to confirm these preliminary observations. In conclusion, we must pay attention to HCV infection in diabetic patients, since a high prevalence of HCV infection is observed and it may have an adverse effect on the progression of diabetic nephropathy. However, the accurate reason for the rapid progression of HCV induced glomerulosclerosis remains uncertain.
In other words, HCV infection in diabetics could be considered as a potential aggravating factor for the microangiopathic complications. Frequent check ups and close monitoring has to be done for diabetics with HCV infection with special consideration to renal and retinal complications.
